Effective control of SARS-CoV-2 transmission between healthcare workers during a period of diminished community prevalence of COVID-19
Previously, we showed that 3% (31/1032)of asymptomatic healthcare workers (HCWs) from a large teaching hospital in Cambridge, UK, tested positive for SARS-CoV-2 in April 2020. About 15% (26/169) HCWs with symptoms of coronavirus disease 2019 (COVID-19) also tested positive for SARS-CoV-2 (Rivett et al., 2020). Here, we show that the proportion of both asymptomatic and symptomatic HCWs testing positive for SARS-CoV-2 rapidly declined to near-zero between 25th April and 24th May 2020, corresponding to a decline in patient admissions with COVID-19 during the ongoing UK ‘lockdown’. These data demonstrate how infection prevention and control measures including staff testing may help prevent hospitals from becoming independent ‘hubs’ of SARS-CoV-2 transmission, and illustrate how, with appropriate precautions, organizations in other sectors may be able to resume on-site work safely..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
eLife - 9(2020) |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Nick K Jones [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
Biology (General) |
---|
doi: |
10.7554/eLife.59391 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ004439406 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ004439406 | ||
003 | DE-627 | ||
005 | 20230307023105.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.7554/eLife.59391 |2 doi | |
035 | |a (DE-627)DOAJ004439406 | ||
035 | |a (DE-599)DOAJ23a09a039e26435589faa0bbe36f41e4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a QH301-705.5 | |
100 | 0 | |a Nick K Jones |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effective control of SARS-CoV-2 transmission between healthcare workers during a period of diminished community prevalence of COVID-19 |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Previously, we showed that 3% (31/1032)of asymptomatic healthcare workers (HCWs) from a large teaching hospital in Cambridge, UK, tested positive for SARS-CoV-2 in April 2020. About 15% (26/169) HCWs with symptoms of coronavirus disease 2019 (COVID-19) also tested positive for SARS-CoV-2 (Rivett et al., 2020). Here, we show that the proportion of both asymptomatic and symptomatic HCWs testing positive for SARS-CoV-2 rapidly declined to near-zero between 25th April and 24th May 2020, corresponding to a decline in patient admissions with COVID-19 during the ongoing UK ‘lockdown’. These data demonstrate how infection prevention and control measures including staff testing may help prevent hospitals from becoming independent ‘hubs’ of SARS-CoV-2 transmission, and illustrate how, with appropriate precautions, organizations in other sectors may be able to resume on-site work safely. | ||
650 | 4 | |a COVID-19 | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a infectious disease | |
650 | 4 | |a virology | |
650 | 4 | |a occupational health | |
650 | 4 | |a emerging pathogens | |
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
653 | 0 | |a Science | |
653 | 0 | |a Q | |
653 | 0 | |a Biology (General) | |
700 | 0 | |a Lucy Rivett |e verfasserin |4 aut | |
700 | 0 | |a Dominic Sparkes |e verfasserin |4 aut | |
700 | 0 | |a Sally Forrest |e verfasserin |4 aut | |
700 | 0 | |a Sushmita Sridhar |e verfasserin |4 aut | |
700 | 0 | |a Jamie Young |e verfasserin |4 aut | |
700 | 0 | |a Joana Pereira-Dias |e verfasserin |4 aut | |
700 | 0 | |a Claire Cormie |e verfasserin |4 aut | |
700 | 0 | |a Harmeet Gill |e verfasserin |4 aut | |
700 | 0 | |a Nicola Reynolds |e verfasserin |4 aut | |
700 | 0 | |a Michelle Wantoch |e verfasserin |4 aut | |
700 | 0 | |a Matthew Routledge |e verfasserin |4 aut | |
700 | 0 | |a Ben Warne |e verfasserin |4 aut | |
700 | 0 | |a Jack Levy |e verfasserin |4 aut | |
700 | 0 | |a William David Córdova Jiménez |e verfasserin |4 aut | |
700 | 0 | |a Fathima Nisha Begum Samad |e verfasserin |4 aut | |
700 | 0 | |a Chris McNicholas |e verfasserin |4 aut | |
700 | 0 | |a Mark Ferris |e verfasserin |4 aut | |
700 | 0 | |a Jane Gray |e verfasserin |4 aut | |
700 | 0 | |a Michael Gill |e verfasserin |4 aut | |
700 | 0 | |a The CITIID-NIHR COVID-19 BioResource Collaboration |e verfasserin |4 aut | |
700 | 0 | |a Martin D Curran |e verfasserin |4 aut | |
700 | 0 | |a Stewart Fuller |e verfasserin |4 aut | |
700 | 0 | |a Afzal Chaudhry |e verfasserin |4 aut | |
700 | 0 | |a Ashley Shaw |e verfasserin |4 aut | |
700 | 0 | |a John R Bradley |e verfasserin |4 aut | |
700 | 0 | |a Gregory J Hannon |e verfasserin |4 aut | |
700 | 0 | |a Ian G Goodfellow |e verfasserin |4 aut | |
700 | 0 | |a Gordon Dougan |e verfasserin |4 aut | |
700 | 0 | |a Kenneth GC Smith |e verfasserin |4 aut | |
700 | 0 | |a Paul J Lehner |e verfasserin |4 aut | |
700 | 0 | |a Giles Wright |e verfasserin |4 aut | |
700 | 0 | |a Nicholas J Matheson |e verfasserin |4 aut | |
700 | 0 | |a Stephen Baker |e verfasserin |4 aut | |
700 | 0 | |a Michael P Weekes |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t eLife |d eLife Sciences Publications Ltd, 2013 |g 9(2020) |w (DE-627)DOAJ000080845 |x 2050084X |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2020 |
856 | 4 | 0 | |u https://doi.org/10.7554/eLife.59391 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/23a09a039e26435589faa0bbe36f41e4 |z kostenfrei |
856 | 4 | 0 | |u https://elifesciences.org/articles/59391 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2050-084X |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 9 |j 2020 |